319
Views
7
CrossRef citations to date
0
Altmetric
Review

New modalities of cancer treatment for NSCLC: focus on immunotherapy

Pages 63-75 | Published online: 03 Feb 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Hongbin Tu, Jing Li, Lei Lin & Lixin Wang. (2021) COL11A1 Was Involved in Cell Proliferation, Apoptosis and Migration in Non-Small Cell Lung Cancer Cells. Journal of Investigative Surgery 34:6, pages 664-669.
Read now
Wenjie Guo, Sihan Liu, Xiaoli Zhang, Yating Chen, Ruolan Qian, Ziyuan Zou, Xin Chen & Peng Luo. (2017) The coexpression of multi-immune inhibitory receptors on T lymphocytes in primary non-small-cell lung cancer. Drug Design, Development and Therapy 11, pages 3367-3376.
Read now
Alex Françoso & Patricia Ucelli Simioni. (2017) Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies. Drug Design, Development and Therapy 11, pages 177-184.
Read now
Carlo Genova, Giovanni Rossi, Erika Rijavec, Federica Biello, Giulia Barletta, Marco Tagliamento & Francesco Grossi. (2017) Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer. Expert Opinion on Drug Safety 16:5, pages 573-585.
Read now
Cecilia Lindskog, Karolina Edlund, Johanna Sofia Margareta Mattsson & Patrick Micke. (2015) Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use?. Expert Review of Molecular Diagnostics 15:4, pages 471-490.
Read now
Austin Huy Nguyen, Ilya G Berim & Devendra K Agrawal. (2014) Cellular and molecular immunology of lung cancer: therapeutic implications. Expert Review of Clinical Immunology 10:12, pages 1711-1730.
Read now